Tech revival sees ASX close 0.7pc higher, Neuren leaps on EU approval hopes — as it happened

The ASX shrugged off a sluggish Wall Street lead to close 0.7 per cent higher as Neuren Pharmaceuticals surged on a potential EU approval for one of its drugs.